Arialys Therapeutics

News

March 11, 2024

Arialys to Present at AAN 2024

At AAN 2024, Mickey Matsumoto, Ph.D., CSO of Arialys, will give an oral presentation entitled, "Peripherally Administered Therapeutic One-armed Antibody Reversed Behavioral Abnormalities in a Marmoset Model of Anti-NMDAR Encephalitis."

‍

View the abstract and more details here.

‍

Sign up for news updates

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

News

Sign up for news updates

Follow us